Collegium Pharmaceutical (COLL) EBT Growth (5y) (2019 - 2026)
Collegium Pharmaceutical (COLL) EBT Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Collegium Pharmaceutical | 897.54 Mn | 748.22 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.44% |
| Mar 31, 2026 | 3.90% |
| Dec 31, 2025 | 31.94% |
| Sep 30, 2025 | 30.30% |
| Jun 30, 2025 | 15.44% |
| Mar 31, 2025 | 47.31% |
| Dec 31, 2024 | 58.00% |
| Sep 30, 2024 | 35.40% |
| Jun 30, 2024 | 52.23% |
| Mar 31, 2024 | 42.00% |
| Dec 31, 2023 | 38.74% |
| Sep 30, 2023 | 17.14% |
| Jun 30, 2023 | 16.33% |
| Mar 31, 2023 | 34.22% |
| Dec 31, 2022 | 14.87% |
| Sep 30, 2022 | 15.83% |
| Jun 30, 2022 | 24.42% |
| Mar 31, 2022 | 9.80% |
| Dec 31, 2021 | -7.08% |
| Sep 30, 2021 | 17.31% |